Chapter 70: Inventor Confirmed
The ruling gave Celeste every title except inventor.
She remained chief executive of Sterling Biotech. Conrad remained chairman. Nathan remained chief legal officer and her fiancé.
The tribunal confirmed me as the primary inventor of the underlying platform.
Three months had passed since the centennial.
The written decision followed the claim map rather than the family story. My early hypothesis memo established the first recorded conception. Theo Bell corroborated the working process he personally observed. The pre-incident author list placed my name first.
For each core claim, the decision identified a contemporaneous record and explained the weight assigned to it. Where memory exceeded documentation, the tribunal narrowed the finding. Where a commercial slide conflicted with a research source, the earlier source controlled scientific credit.
The Zurich archive proved I presented the core relationship fourteen months before Celeste's claimed origin date. Julian's notebook supported that record but was not treated as decisive because of his current conflict.
Celeste's evidence received its own findings.
The three-name slide was a financing document created after the research period. Her brand team's account changed author order after the incident but did not prove she personally edited a file. Her rehearsed description used my earlier language. Her email mocked the direction instead of contributing a mapped improvement.
Nathan's instruction removed my name from investor materials. It proved active suppression of attribution after the incident, not authority to change patent inventorship.
The tribunal stated the result in two lines:
EVELYN STERLING—PRIMARY INVENTOR CONFIRMED.
CELESTE STERLING—CO-INVENTOR CLAIM DENIED.
The registry would attach the ruling to the existing patent record after the appeal window. It would not create a new patent or change the trust's ownership.
Scientific credit had moved. Corporate control had not.
The ruling drew the boundary permanently in ink.
Celeste read the order at Sterling's counsel table.
"This tribunal is rewarding paperwork over leadership," she said.
"It is deciding inventorship from contribution records," the chair replied.
Conrad asked whether Sterling retained rights to the platform.
"Ownership remains with Helena Research Trust under the existing patent record," the chair said. "Sterling's license status is governed by separate proceedings."
The ruling did not give me Sterling shares, a board seat, an executive title, or control of the company. It did not lift the formal license suspension, award rights to Mercer Nova, or decide the FBRA trial hold.
My observer badge still said NONVOTING.
That boundary did not weaken the victory. Celeste had built her crown around the claim that she was the scientist who created Sterling's future. The independent record removed that scientific identity without pretending one decision solved every other wrong.
Nathan reserved Sterling's appeal rights. He did not apologize for the email or step away from Celeste.
She announced that she would continue leading the company.
No one stopped her.
The order reached the public patent record that afternoon. For the first time, the listing was supported not only by the trust's original filing but by a completed adversarial review.
Reporters gathered outside the tribunal.
"Did you take your sister's company?" one asked.
"No."
"Will you replace her as CEO?"
"This ruling does not appoint anyone."
"Then what did you win?"
I looked at the published finding.
"The right contribution is attached to the right name."
That was enough.
Mercer Nova sent a procedural congratulations message through my office. Julian did not appear at the cameras or claim a place in the result. His team planned a private celebration after work.
Before I accepted, I checked the public order for every participant reference.
The tribunal had used sealed identifiers and excluded Leah's name.
The order was clean.
The coverage beginning around it was not.
Before I celebrated my own name, I needed to know whose name someone else was trying to expose.